Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19
NCT04467151
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Did not obtain funding to proceed with study
Conditions
COVID-19
Interventions
DRUG:
anti-SARS-CoV-2 plasma
OTHER:
Placebo
Sponsor
Kashif Khan